News | Blood Testing | March 01, 2017

New Heart Attack Evaluation Cuts Unnecessary Tests, Time in ER

Safe approach could help nearly 10 million Americans seen each year for chest pain

heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study

March 1, 2017 — Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a highly sensitive, newly U.S. Food and Drug Administration (FDA)-approved blood test and a heart health scoring system. These findings were drawn from an international study led by Henry Ford Health System.

That is good news for 8 to 10 million Americans seen for chest pain each year in emergency rooms, said Henry Ford cardiologist James McCord, M.D. Studies show a heart attack is ruled out for about 85 percent of those patients.

“People can appreciate if you’re in the ER for two hours versus 30 hours — that’s a big deal,” said McCord, estimating that about 40 percent — or approximately 3.5 million patients — who pass the testing could go home quickly. “The patients not only have a heart attack ruled out, they represent a low-risk group of patients who can go home from the ER without further observation or cardiac testing, like a stress test.”

The study was recently published online and will appear in the March print issue of the American Heart Association’s Circulation: Cardiovascular Quality and Outcomes. Twelve hospitals around the world participated, including Henry Ford and the University of Maryland in the United States.

Emergency rooms around the world for years have been diagnosing heart attacks using a blood test that measures the protein troponin, which the heart releases during a heart attack. But a more sensitive troponin test available in Europe and other parts of the world was just approved for use in the United States by the FDA in February.

For the study, the researchers focused on 1,282 patients from 2011 through 2013 who had chest pain and were evaluated in emergency rooms for possible heart attacks. For this study, and separately from the patients’ medical treatment, the researchers asked the patients for permission to test their blood using the new, sensitive troponin test. The researchers also scored the patients with a heart health evaluation called the Heart Score. The Heart Score looks at the patient’s heart health history, the results of an electrocardiogram (ECG) done in the ER, the person’s age, and their risk factors like smoking, hypertension and diabetes.

Within 30 days, 217 of the patients had either a heart attack or died. In the 515 patients that had a low Heart Score and normal troponin blood tests over 1 hour, the chance of a heart attack or death at 30 days was only 0.2 percent.

Those are the patients — 40 percent of patients in the study — that likely could safely go home quickly, saving time and thousands of dollars for both the patients and hospitals, said McCord.

“Currently, many of these patients stay in an observation unit for hours, then get a stress test or cardiac imaging, which takes a day or more to accomplish,” said McCord. “It’s huge not only from the hospital perspective because it takes time and money to hold the patients, get a test, review the tests and make a decision — there is the time that the patient is out of the workforce. If you put that into the equation, that’s another large part of the financial impact equation.”

Now that the more sensitive troponin test is offered in the United States and ER evaluation data is available, McCord said hospitals will be deciding how to move forward. The new troponin test requires the addition of testing equipment.

“It’s showing where we are headed in the future,” said McCord. “Institutions, including our own, are looking at the data and deciding how to incorporate it into our patient evaluation. There wasn’t even the availability of using it until very recently. We’re behind the rest of the world; now the door’s opening for us to use these novel tests.”

Read the article "Highly-sensitive Troponin Test Can Detect Myocardial Injury After Non-Cardiac Surgery."

Read the article “Common Troponin Blood Test May Predict Future Hypertension.”

Read the article “New Data for Abbott's Investigational High Sensitive Troponin Test May Help Predict Heart Attack Risk”

For more information:


McCord, J., Cabrera, R., Lindahl, B., Giannitsis, E., et al. "Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department," Circulation: Cardiovascular Quality and Outcomes. Published online Feb. 6, 2017. DOI:

Related Content

FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
Technology | Blood Testing | October 09, 2019
Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from...
Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes
News | Blood Testing | September 18, 2019
Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-sensitivity cardiac troponin T...
Validation Studies Confirm High Accuracy of Novel HART AI-Driven Blood Tests
News | Blood Testing | March 19, 2019
Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven, multiple-protein...
CoaguChek XS PT Test Strips Recalled for Inaccurately Reporting High INR
News | Blood Testing | December 28, 2018
Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as...
Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis
News | Blood Testing | October 26, 2018
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether...
New Noninvasive Blood Glucose Test as Effective as Finger Prick

Image courtesy of University of Missouri School of Medicine

News | Blood Testing | October 24, 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related...
Abbott Receives CE Mark for High Sensitive Troponin-I Test
News | Blood Testing | October 16, 2018
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I...
AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018
Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD)...
More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018
August 6, 2018 — A new test to assess a whether or not someone is having a...
Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018
March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singule